Analyze Diet
Journal of veterinary pharmacology and therapeutics2013; 36(1); 31-42; doi: 10.1111/j.1365-2885.2013.01389.x

A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite.

Abstract: We describe the population pharmacokinetics of an acepromazine (ACP) metabolite (2-(1-hydroxyethyl)promazine) (HEPS) in horses for the estimation of likely detection times in plasma and urine. ACP (30 mg) was administered to 12 horses, and blood and urine samples were taken at frequent intervals for chemical analysis. A bayesian hierarchical model was fitted to describe concentration-time data and cumulative urine amounts for HEPS. The metabolite HEPS was modelled separately from the parent ACP as the half-life of the parent was considerably less than that of the metabolite. The clearance (Cl/F(PM)) and volume of distribution (V/F(PM)), scaled by the fraction of parent converted to metabolite, were estimated as 769 L/h and 6874 L, respectively. For a typical horse in the study, after receiving 30 mg of ACP, the upper limit of the detection time was 35 h in plasma and 100 h in urine, assuming an arbitrary limit of detection of 1 lg/L and a small (≈0.01) probability of detection. The model derived allowed the probability of detection to be estimated at the population level. This analysis was conducted on data collected from only 12 horses, but we assume that this is representative of the wider population.
Publication Date: 2013-01-16 PubMed ID: 23317425DOI: 10.1111/j.1365-2885.2013.01389.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers investigated the pharmacokinetics (how the body processes a drug) of a metabolite of acepromazine in horses to estimate how long it would likely be detectable in blood and urine. Assuming a very low detection limit and small detection chance, they found the upper limit of detection time to be 35 hours in blood and 100 hours in urine.

Introduction

This research aims to establish the duration during which a metabolite of acepromazine (ACP), a drug often used in horses, can be detected in the horse’s plasma and urine. This knowledge is significant for understanding how long after administration the drug can potentially be detected in doping tests. Pharmaceuticals are metabolized into other substances, one of them being 2-(1-hydroxyethyl)promazine (HEPS) in this case, which happens to have a longer half-life than the parent drug, ACP.

Methodology

  • Twelve horses were administered a controlled dose of 30 mg ACP and tested systematically. Blood and urine samples were collected regularly for chemical analysis.
  • A Bayesian hierarchical model was employed to interpret the collected time-concentration data, as well as the cumulative urine amounts of the metabolite HEPS.
  • HEPS was analyzed independently from ACP due to its longer half-life.

Data Analysis and Results

  • The calculated clearance (Cl/F(PM)) and the volume of distribution (V/F(PM)), scaled by the conversion fraction of the parent to metabolite, were estimated at 769 L/h and 6874 L, respectively.
  • For a standard horse from the study, 30 mg of ACP produced a maximum detection span of 35 hours in plasma and 100 hours in urine given a detection limit of 1 lg/L with a probability of detection almost negligible (roughly 0.01).

Conclusions

  • The model allows an estimation of the probability of detection on a population level.
  • The research was carried out on a controlled group of 12 horses, and this data was used to make assumptions regarding a wider population.
  • This study provides valuable insight into how long ACP can be detected in horse’s systems, potentially informing drug administration strategies and detection plans in equestrian sport.

Cite This Article

APA
McGree JM, Noble G, Schneiders F, Dunstan AJ, McKinney AR, Boston R, Sillence M. (2013). A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite. J Vet Pharmacol Ther, 36(1), 31-42. https://doi.org/10.1111/j.1365-2885.2013.01389.x

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 36
Issue: 1
Pages: 31-42

Researcher Affiliations

McGree, J M
  • Mathematical Sciences, Queensland University of Technology, Brisbane, Qld, Australia. james.mcgree@qut.edu.au
Noble, G
    Schneiders, F
      Dunstan, A J
        McKinney, A R
          Boston, R
            Sillence, M

              MeSH Terms

              • Acepromazine / blood
              • Acepromazine / pharmacokinetics
              • Acepromazine / urine
              • Animals
              • Bayes Theorem
              • Doping in Sports / methods
              • Horses / blood
              • Horses / metabolism
              • Horses / urine
              • Hypnotics and Sedatives / blood
              • Hypnotics and Sedatives / pharmacokinetics
              • Hypnotics and Sedatives / urine
              • Male
              • Probability

              Citations

              This article has been cited 1 times.
              1. Toutain PL. Why the racing industry and equestrian disciplines need to implement population pharmacokinetics: To learn, explain, summarize, harmonize, and individualize. Drug Test Anal 2025 Feb;17(2):250-258.
                doi: 10.1002/dta.3706pubmed: 38685692google scholar: lookup